Rathbones Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-11,114
| Closed | -$1.13M | – | 657 |
|
|
2025
Q4 | $1.13M | Hold |
11,114
| – | – | ﹤0.01% | 352 |
|
|
2025
Q3 | $608K | Sell |
11,114
-2,200
| -17% | -$110K | ﹤0.01% | 421 |
|
|
2025
Q2 | $708K | Sell |
13,314
-400
| -3% | -$20.3K | ﹤0.01% | 384 |
|
|
2025
Q1 | $594K | Hold |
13,714
| – | – | ﹤0.01% | 393 |
|
|
2024
Q4 | $771K | Hold |
13,714
| – | – | ﹤0.01% | 360 |
|
|
2024
Q3 | $934K | Hold |
13,714
| – | – | ﹤0.01% | 338 |
|
|
2024
Q2 | $579K | Hold |
13,714
| – | – | ﹤0.01% | 392 |
|
|
2024
Q1 | $947K | Hold |
13,714
| – | – | 0.01% | 332 |
|
|
2023
Q4 | $1.01M | Hold |
13,714
| – | – | 0.01% | 313 |
|
|
2023
Q3 | $936K | Buy |
13,714
+914
| +7% | +$77.5K | 0.01% | 326 |
|
|
2023
Q2 | $1.2M | Hold |
12,800
| – | – | 0.01% | 233 |
|
|
2023
Q1 | $868K | Hold |
12,800
| – | – | 0.01% | 260 |
|
|
2022
Q4 | $634K | Hold |
12,800
| – | – | 0.01% | 274 |
|
|
2022
Q3 | $416K | Hold |
12,800
| – | – | 0.01% | 302 |
|
|
2022
Q2 | $504K | Hold |
12,800
| – | – | 0.01% | 295 |
|
|
2022
Q1 | $895K | Hold |
12,800
| – | – | 0.01% | 258 |
|
|
2021
Q4 | $996K | Hold |
12,800
| – | – | 0.01% | 253 |
|
|
2021
Q3 | $1.22M | Hold |
12,800
| – | – | 0.01% | 233 |
|
|
2021
Q2 | $1.59M | Hold |
12,800
| – | – | 0.02% | 224 |
|
|
2021
Q1 | $1.69M | Hold |
12,800
| – | – | 0.02% | 207 |
|
|
2020
Q4 | $1.7M | Hold |
12,800
| – | – | 0.02% | 197 |
|
|
2020
Q3 | $1.3M | Hold |
12,800
| – | – | 0.02% | 200 |
|
|
2020
Q2 | $1.11M | Hold |
12,800
| – | – | 0.02% | 199 |
|
|
2020
Q1 | $742K | Hold |
12,800
| – | – | 0.02% | 190 |
|
|
2019
Q4 | $1.18M | Hold |
12,800
| – | – | 0.03% | 185 |
|
|
2019
Q3 | $1.16M | Hold |
12,800
| – | – | 0.03% | 184 |
|
|
2019
Q2 | $1.51M | Hold |
12,800
| – | – | 0.05% | 156 |
|
|
2019
Q1 | $1.11M | Hold |
12,800
| – | – | 0.04% | 172 |
|
|
2018
Q4 | $808K | Hold |
12,800
| – | – | 0.03% | 184 |
|
|
2018
Q3 | $1.01M | Hold |
12,800
| – | – | 0.03% | 176 |
|
|
2018
Q2 | $765K | Hold |
12,800
| – | – | 0.03% | 182 |
|
|
2018
Q1 | $516K | Hold |
12,800
| – | – | 0.02% | 211 |
|
|
2017
Q4 | $673K | Hold |
12,800
| – | – | 0.03% | 196 |
|
|
2017
Q3 | $603K | Sell |
12,800
-300
| -2% | -$12.1K | 0.03% | 205 |
|
|
2017
Q2 | $463K | Hold |
13,100
| – | – | 0.02% | 218 |
|
|
2017
Q1 | $309K | Hold |
13,100
| – | – | 0.01% | 248 |
|
|
2016
Q4 | $175K | Buy |
+13,100
| New | +$211K | 0.01% | 287 |
|
|
2015
Q3 | – | Sell |
-7,400
| Closed | -$220K | – | 311 |
|
|
2015
Q2 | $220K | Buy |
+7,400
| New | +$186K | 0.01% | 279 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Rathbones Group's EXAS Position: Q1 2026 in Review
Rathbones Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 11,114 shares — an estimated $1.13M sold.
Rathbones Group first reported a position in EXAS in Q2 2015 and held it in 38 quarters. The position peaked at $1.7M in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Rathbones Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Rathbones Group sold 11,114 Exact Sciences shares in Q1 2026, an estimated $1.13M.
- Rathbones Group first reported a position in Exact Sciences in Q2 2015 and held it in 38 quarters.
- Rathbones Group's Exact Sciences position peaked at $1.7M in Q4 2020.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.